Friday, April 23, 2021
12:45 p.m. CET
User
Favorite list
As a global market leader with numerous subsidiaries and distributors, Miltenyi Biotec is committed to providing our customers around the world with the highest quality products. In addition to direct selling in more than 20 countries in North America, Europe and Asia/Pacific, Miltenyi Biotec also provides support for our customers through an extensive distributor network covering dozens of additional countries.
April 22–24, 2021
The European Society for Clinical Cell Analysis (ESCCA) is an association of European professional scientists working in the field of cell measurement for diagnostic and therapeutic purposes, utilizing advanced technologies. Every year, over 400 delegates from all over the world come together to exchange scientific knowledge and contacts with colleagues. The ESCCA Conference has become a major platform for education and scientific exchange in the fields of basic, translational, and clinical applications in cytometry embracing the area of pathology, immunology, hematology, cancer, aging, regenerative medicine and microbiology. Visit us in the virtual exhibition hall to explore our latest technologies to simplify your cell manufacturing analytics.
Moreover, conference attendees as well as general science enthusiasts driven for CAR T cell therapy have the opportunity to join our free talk by Michal Besser (Sheba Medical Center, Israel). She will emphasize the importance and advantages of on-site production of CAR T cells and shares insights into CAR T detection as part of quality control (QC) and patient monitoring.
Register by completing the form below and tune into this free scientific talk.
Find out more about the ESCCA Conference here.
Tune into this scientific talk by Dr. Michal Besser and hear about the importance of on-site CAR T cell production. Learn from her experiences with over 200 CAR T cell procedures perfomed and find out which tools help her to streamline QC assays and patient monitoring.
The presentation will focus on:
• comparison of CD19 CAR T cell production for NHL and ALL patients
• advantages of on-site CAR T production
• QC requirements for on-site CAR T production
Sheba Medical Center, Israel
Michal Besser, Ph.D. is the head of laboratory at The Ella Lemelbaum Institute for Immuno-Oncology and the scientific director of the ABC GMP facility at the Sheba Medical Center in Israel. Dr. Besser is an Assistant Professor at the Department of Clinical Immunology and Microbiology at Tel Aviv University. She completed her undergraduate studies and Ph.D. at the University of Munich, Germany, and her postdoctoral research at the Weizmann Institute of Science, Israel. The Besser lab is specialized in the clinical production of CAR T cells and Tumor Infiltrating Lymphocytes (TIL) for therapy of cancer patients. Adoptive cell therapy serves as a platform for a wide range of research projects, which mainly seek the understanding and improvement of cellular therapies and immunotherapy.
Copyright © 2021 Miltenyi Biotec and/or its affiliates. All rights reserved.
